SCHEMBL8020265

SCHEMBL8020265

CCN1/C(=C/C(O)C(C)(C)C)Sc2ccc(OC)cc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.62
KMT2A Q03164 7/20 0.62
MAPT P10636 5/20 0.62
DYRK1A Q13627 5/20 0.62
HSD17B10 Q99714 4/20 0.62
CSNK1E P49674 3/20 0.62
CLK1 P49759 3/20 0.62
CLK3 P49761 3/20 0.62
DYRK1B Q9Y463 3/20 0.62
ALDH1A1 P00352 3/20 0.62
HTT P42858 3/20 0.62
NPSR1 Q6W5P4 3/20 0.62
BLM P54132 3/20 0.62
LMNA P02545 3/20 0.62
PIM1 P11309 2/20 0.62
CSNK1D P48730 2/20 0.62
CSNK1G2 P78368 2/20 0.62
MAP3K19 Q56UN5 2/20 0.62
PIM3 Q86V86 2/20 0.62
CSNK1G3 Q9Y6M4 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8030001 0.86 MEN1 (0.66) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL8035944 0.81 DYRK1A (0.60) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL24534821 0.79 DYRK1A (0.70) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL8033425 0.77 MAPT (0.56) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL8040989 0.77 DYRK1A (0.66) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL2977830 0.77 DYRK1A (1.00) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL2977826 0.77 DYRK1A (1.00) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL8033454 0.76 MEN1 (0.53) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL4157023 0.76 DYRK1A (0.76) MEN1KMT2AMAPTDYRK1AHSD17B10
SCHEMBL4157020 0.76 DYRK1A (0.76) MEN1KMT2AMAPTDYRK1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed